The DOI matches its Crossref record; 37 of the 37 references it cites were found in a registry or an index.
Anti-RhoA and Anti-RhoC siRNAs Inhibit the Proliferation and Invasiveness of MDA-MB-231 Breast Cancer Cells in Vitro and in Vivo
Open accessAbstract
Overexpression of RhoA or RhoC in breast cancer indicates a poor prognosis, due to increased tumor cell proliferation and invasion and tumor-dependent angiogenesis. Until now, the strategy of blockage of the Rho-signaling pathway has used either GGTI or HMG-CoA reductase inhibitors, but they are not specific to RhoA or RhoC inhibition. In this study, a new approach with anti-RhoA and anti-RhoC siRNAs was used to inhibit specifically RhoA or RhoC synthesis. Two transfections of either RhoA or RhoC siRNA (8.5 nM) into MDA-MB-231 human breast cancer cells or HMEC-1 endothelial cells induced extensive degradation of the target mRNA and led to a dramatic decrease in synthesis of the corresponding protein. In vitro, these siRNAs inhibited cell proliferation and invasion more effectively than conventional blockers of Rho cell signaling. Finally, in a nude mouse model, intratumoral injections of anti-RhoA siRNA (100 microl at 85 nM) every 3 days for 20 days almost totally inhibited the growth and angiogenesis of xenografted MDA-MB-231 tumors. One may infer from these observations that specific inhibition of the Rho-signaling pathway with siRNAs represents a promising approach for the treatment of aggressive breast cancers.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Bradford, M. M. (1976) · Analytical Biochemistry · doi:10.1016/0003-2697(76)90527-3 · Cited by 255,302
Dignam, J. D., Lebovitz, R. M., & Roeder, R. G. (1983) · Nucleic Acids Research · doi:10.1093/nar/11.5.1475 · Cited by 11,260
Tumor Angiogenesis and Metastasis — Correlation in Invasive Breast Carcinoma
Weidner, N., Semple, J. P., Welch, W. R., & Folkman, J. (1991) · New England Journal of Medicine · doi:10.1056/nejm199101033240101 · Cited by 5,627
Functional anatomy of siRNAs for mediating efficient RNAi in Drosophila melanogaster embryo lysate
Elbashir, S. M. (2001) · The EMBO Journal · doi:10.1093/emboj/20.23.6877 · Cited by 1,449
Genomic analysis of metastasis reveals an essential role for RhoC
Clark, E. A., Golub, T. R., Lander, E. S., & Hynes, R. O. (2000) · Nature · doi:10.1038/35020106 · Cited by 1,445
Pleiotropic Effects of 3-Hydroxy-3-Methylglutaryl Coenzyme A Reductase Inhibitors
Takemoto, M., & Liao, J. K. (2001) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/hq1101.098486 · Cited by 1,272
HMEC-1: Establishment of an Immortalized Human Microvascular Endothelial Cell Line
Ades, E. W., Candal, F. J., Swerlick, R. A., George, V. G., Summers, S., Bosse, D. C., & Lawley, T. J. (1992) · Journal of Investigative Dermatology · doi:10.1111/1523-1747.ep12613748 · Cited by 1,265
Sahai, E., & Marshall, C. J. (2002) · Nature Reviews Cancer · doi:10.1038/nrc725 · Cited by 1,261
Sahai, E., & Marshall, C. J. (2003) · Nature Cell Biology · doi:10.1038/ncb1019 · Cited by 1,147
Lin, S.-Y., Xia, W., Wang, J. C., Kwong, K. Y., Spohn, B., Wen, Y., Pestell, R. G., & Hung, M.-C. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.060025397 · Cited by 783
Rho GTPases are over-expressed in human tumors
Fritz, G., Just, I., & Kaina, B. (1999) · International Journal of Cancer · doi:10.1002/(sici)1097-0215(19990531)81:5<682::aid-ijc2>3.0.co;2-b · Cited by 659
Rho GTPases: Signaling, Migration, and Invasion
Schmitz, A. A. P., Govek, E.-E., Böttner, B., & Van Aelst, L. (2000) · Experimental Cell Research · doi:10.1006/excr.2000.5049 · Cited by 578
Comparison of antisense oligonucleotides and siRNAs in cell culture and in vivo
Bertrand, J.-R., Pottier, M., Vekris, A., Opolon, P., Maksimenko, A., & Malvy, C. (2002) · Biochemical and Biophysical Research Communications · doi:10.1016/s0006-291x(02)02013-2 · Cited by 400
Self-citationExpanding small RNA interference
Tuschl, T. (2002) · Nature Biotechnology · doi:10.1038/nbt0502-446 · Cited by 395
Bouïs, D., Hospers, G. A. P., Meijer, C., Molema, G., & Mulder, N. H. (2001) · Angiogenesis · doi:10.1023/a:1012259529167 · Cited by 379
Rho signals to cell growth and apoptosis
Aznar, S., & Lacal, J. C. (2001) · Cancer Letters · doi:10.1016/s0304-3835(01)00412-8 · Cited by 310
Denoyelle, C. (2001) · Carcinogenesis · doi:10.1093/carcin/22.8.1139 · Cited by 310
Self-citationSebti, S. M., & Hamilton, A. D. (2000) · Oncogene · doi:10.1038/sj.onc.1204146 · Cited by 279
Pedersen, T. R., Wilhelmsen, L., Færgeman, O., Strandberg, T. E., Thorgeirsson, G., Troedsson, L., Kristianson, J., Berg, K., Cook, T. J., Haghfelt, T., et al. (2000) · The American Journal of Cardiology · doi:10.1016/s0002-9149(00)00910-3 · Cited by 274
Membrane Association and Targeting of Prenylated Ras-like GTPases
Seabra, M. C. (1998) · Cellular Signalling · doi:10.1016/s0898-6568(97)00120-4 · Cited by 261
Lobell, R. B., Omer, C. A., Abrams, M. T., Bhimnathwala, H., Brucker, M. J., Buser, C. A., Davide, J. P., DeSolms, S. J., Dinsmore, C. J., Ellis-Hutchings, M., et al. (2001) · PubMed · Cited by 239
Horiuchi, A., Imai, T., Wang, C., Ohira, S., Feng, Y., Nikaido, T., & Konishi, I. (2003) · Laboratory Investigation · doi:10.1097/01.lab.0000073128.16098.31 · Cited by 233
Kusama, T., Mukai, M., Iwasaki, T., Tatsuta, M., Matsumoto, Y., Akedo, H., Inoue, M., & Nakamura, H. (2002) · Gastroenterology · doi:10.1053/gast.2002.31093 · Cited by 217
Vincent, L., Chen, W., Hong, L., Mirshahi, F., Mishal, Z., Mirshahi-Khorassani, T., Vannier, J.-P., Soria, J., & Soria, C. (2001) · FEBS Letters · doi:10.1016/s0014-5793(01)02337-7 · Cited by 201
Self-citationChen, Z., Sun, J., Pradines, A., Favre, G., Adnane, J., & Sebti, S. M. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.c000145200 · Cited by 198
Akt Mediates Ras Downregulation of RhoB, a Suppressor of Transformation, Invasion, and Metastasis
Jiang, K., Sun, J., Cheng, J., Djeu, J. Y., Wei, S., & Sebti, S. (2004) · Molecular and Cellular Biology · doi:10.1128/mcb.24.12.5565-5576.2004 · Cited by 182
Farnesyl transferase inhibitors as anticancer agents
Haluska, P., Dy, G. K., & Adjei, A. A. (2002) · European Journal of Cancer · doi:10.1016/s0959-8049(02)00166-1 · Cited by 159
Characterization of RhoC Expression in Benign and Malignant Breast Disease
Kleer, C. G., van Golen, K. L., Zhang, Y., Wu, Z.-F., Rubin, M. A., & Merajver, S. D. (2002) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)64877-8 · Cited by 157
Regulation of the cytoskeleton by Rho-family GTPases: implications for tumour cell invasion
Price, L., & Collard, J. G. (2001) · Seminars in Cancer Biology · doi:10.1006/scbi.2000.0367 · Cited by 137
Vincent, L., Soria, C., Mirshahi, F., Opolon, P., Mishal, Z., Vannier, J., Soria, J., & Li, H. (2002) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.0000012283.15789.67 · Cited by 129
Self-citationDenoyelle, C., Albanese, P., Uzan, G., Li, H., Vannier, J., Soria, J., & Soria, C. (2003) · Cellular Signalling · doi:10.1016/s0898-6568(02)00124-9 · Cited by 120
Self-citationAdTIMP-2 Inhibits Tumor Growth, Angiogenesis, and Metastasis, and Prolongs Survival in Mice
Li, H., Lindenmeyer, F., Grenet, C., Opolon, P., Ménashi, S., Soria, C., Yeh, P., Perricaudet, M., & Lu, H. (2001) · Human Gene Therapy · doi:10.1089/104303401300042429 · Cited by 102
Self-citationImamura, F., Mukai, M., Ayaki, M., & Akedo, A. H. (2000) · Japanese Journal of Cancer Research · doi:10.1111/j.1349-7006.2000.tb01018.x · Cited by 99
Advances in Rho-dependent actin regulation and oncogenic transformation
Frame, M. C., & Brunton, V. G. (2002) · Current Opinion in Genetics & Development · doi:10.1016/s0959-437x(01)00261-1 · Cited by 89
The Ras Signaling Pathway in Mammary Tumorigenesis and Metastasis
Malaney, S., & Daly, R. J. (2001) · Journal of Mammary Gland Biology and Neoplasia · doi:10.1023/a:1009572700317 · Cited by 85
Clinical Significance of Pleiotropic Effects of Statins: Lipid Reduction and Beyond
Auer, J., Berent, R., Weber, T., & Eber, B. (2002) · Current Medicinal Chemistry · doi:10.2174/0929867023369024 · Cited by 56
Inhibiting Ras Signaling in the Therapy of Breast Cancer
Li, T., & Sparano, J. A. (2003) · Clinical Breast Cancer · doi:10.3816/cbc.2003.n.005 · Cited by 38
Cited by
Demierre, M.-F., Higgins, P. D. R., Gruber, S. B., Hawk, E., & Lippman, S. M. (2005) · Nature Reviews Cancer · doi:10.1038/nrc1751 · Cited by 819
Rho GTPases in cancer cell biology
Vega, F. M., & Ridley, A. J. (2008) · FEBS Letters · doi:10.1016/j.febslet.2008.04.039 · Cited by 779
Progress towards in Vivo Use of siRNAs
Behlke, M. A. (2006) · Molecular Therapy · doi:10.1016/j.ymthe.2006.01.001 · Cited by 677
Hu-Lieskovan, S., Heidel, J. D., Bartlett, D. W., Davis, M. E., & Triche, T. J. (2005) · Cancer Research · doi:10.1158/0008-5472.can-05-0565 · Cited by 567
Nonviral delivery of synthetic siRNAs in vivo
Akhtar, S., & Benter, I. F. (2007) · Journal of Clinical Investigation · doi:10.1172/jci33494 · Cited by 464
Metadata
- Authors
- Pillé, J.-Y., Denoyelle, C., Varet, J., Bertrand, J.-R., Soria, J., Opolon, P., Lu, H., Pritchard, L.-L., Vannier, J.-P., Malvy, C., Soria, C., & Li, H.
- Venue
- Molecular Therapy
- Publisher
- Elsevier BV
- Published
- 2005-02
- Volume
- 11
- Issue
- 2
- Pages
- 267-274
- ISSN
- 1525-0016 (ISSN-L)
- OpenAlex
- W1483934283
- Cited by
- 263
- References
- 37
- FWCI
- 4.92
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.